Oncolytic Virus/CAR T-Cell Therapy Combo Shows Preclinical Potential in Solid Tumors
Solid tumors are surrounded by an immunosuppressive tumor microenvironment. Therefore, when CAR T cells try to enter the tumor, survive, and kill the cancer cells, they cannot do so effectively.City of Hope has therefore developed with the immuno-oncology company Imugene Ltd. a therapy combining an oncolytic virus and CAR T cells that shows preclinical potential […]
